NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

AI醫療診斷的全球市場規模:解決方案,技術,用途,終端用戶,各地區,趨勢分析,市場競爭模式及展望(2020年∼2026年)

Global Artificial Intelligence Diagnostic Market Size, By Solution, By Technology, By Application, By End User, By Region, Trend Analysis, Market Competition Scenario & Outlook, 2020-2026.

出版商 Blueweave Consulting & Research Private Limited 商品編碼 954899
出版日期 內容資訊 英文 161 Pages
商品交期: 最快1-2個工作天內
價格
AI醫療診斷的全球市場規模:解決方案,技術,用途,終端用戶,各地區,趨勢分析,市場競爭模式及展望(2020年∼2026年) Global Artificial Intelligence Diagnostic Market Size, By Solution, By Technology, By Application, By End User, By Region, Trend Analysis, Market Competition Scenario & Outlook, 2020-2026.
出版日期: 2020年07月01日內容資訊: 英文 161 Pages
簡介

2019年,全球AI醫療診斷市場規模達到2.881億美元。從2020年到2027年的預測期內,該市場預計將以32.3%的複合年增長率增長,到2027年將達到204.391億美元。減少診斷成本和設備停機時間,以及對改善患者護理的要求不斷提高,推動了AI在醫學診斷中的接受度。此外,對低成本診斷方法,實際功能強大的報告測試以及快速診斷數據生成的需求不斷增長,這些都是推動市場增長的因素。

本報告提供全球AI醫療診斷市場的相關調查,市場成長及阻礙因素,機會,課題,佔有率,解決方案·技術·用途·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查架構

第2章 調查手法

第3章 摘要整理

第4章 全球市場分析

  • 產業的價值鏈分析
  • DROC分析
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 技術形勢
  • 法律規範
  • 企業的市場佔有率分析(2019)
  • 波特的五力分析
  • 策略性展望

第5章 全球人工智能診斷市場概要

  • 市場估計·各銷售額預測(2016-2026)
    • 各銷售額
  • 市場佔有率與預測
    • 各解決方案
      • 硬體設備
      • 軟體
      • 其他
    • 各技術
      • 語音辨識
      • 查詢方法
      • 自然語言處理
      • 機器學習
      • 情境認識處理
    • 各用途
      • 成像·診斷
      • 藥物研發
      • 生活方式管理·監測
      • 緊急治療室·醫院管理
      • 見解與風險分析
      • 穿戴式
      • 虛擬助手
      • 其他
    • 各終端用戶
      • 醫院
      • 製藥企業
      • 診斷中心
      • 診所
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區
      • 南美
      • 中東·非洲

第6章 北美

第7章 歐洲

第8章 亞太地區

第9章 南美

第10章 中東及非洲

第11章 企業簡介 (企業概要,財務矩陣,產品形勢,主要人力資源,主要其他競爭公司,聯絡原住所,及策略性展望)

  • IBM Corporation
  • Google, Inc.
  • NVIDIA Corporation
  • Microsoft Corporation
  • ICarbonX
  • Next IT Corp.
  • CloudMex Inc.
  • Carescore
  • Atomwise Inc.
  • Zephyr Health Inc.
  • Deep Genomics Inc.
  • Medtronic Plc.
  • Koninkiljke Philips N.V.
  • Oncora Medical, Inc.

第12章 策略性建議

目錄
Product Code: BWC20108

Title:
Global Artificial Intelligence Diagnostic Market Size, By Solution (Hardware and Software & Services), By Technology (Speech Recognition, Querying Method, Natural Language Processing, Machine Learning, and Context-Aware Processing), By Application (Imaging & Diagnostics, Drug Discovery, Lifestyle Management & Monitoring, Emergency Room & Hospital Management, Insights & Risk Analytics, Wearables, Virtual Assistants, and Others), By End User (Hospitals, Pharmaceutical Organizations, Diagnostic Centers, and Clinics), By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa), Trend Analysis, Market Competition Scenario & Outlook, 2020-2026..

The Global AI Diagnostic market to witness massive growth at Exceptional CAGR of 32.3% increasing its valuation 7X by 2027

According to BlueWeave Consulting, the Global Artificial Intelligence Diagnostic Market is anticipated to reach USD 2043.91 million by 2027 from USD 288.1 million in 2019, at a CAGR of 32.3% during the forecast period 2020-2027. Growing requirement for reducing diagnostic costs and machine down time and improving patient care, drive the acceptance and application of artificial intelligence in healthcare diagnostics. Besides, growing requests for low-cost diagnostic methods, actual and competent report testing and quick diagnostic data generation are some of the other factors propel the market for AI in diagnostics.

Artificial intelligence (AI) is used in healthcare to approximate human perception and derive findings of complicated medical and diagnostic imaging data. It plays a critical role in determining the relationship between treatment techniques and patient outcomes in healthcare. AI programs are deployed in multiple medical implications such as diagnostic procedures, drug growth, personalized medicines, and patient testing care. AI cloud is useful in clinical procedures to check the vital signs, probing questions, and giving patients prescriptions. AI systems can also be used for warnings and reminders, image interpretation, information retrieval, and treatment plan during medical procedures.

Deep learning technology of AI is used extensively for image acknowledgement, signal recognition, and data removal. AI can discern more useful patterns than human eyes. It paves the way for the emergence of a new age medical diagnostic devices proficient in surpassing diagnosis skills of the best doctors. As neural networks in artificial intelligence can imagine, a significant number of patients can avail the advantage of its proficiency. Moreover, increasing strategic partnerships and collaborations among numerous AI solution providers and health facilities positively influences market development.

"The software segment plays a vital role in the Artificial Intelligence Diagnostics Market."

Software segment in the AI healthcare market is expected to witness the highest CAGR during the forecast period. Many companies are engaged in developing new software solutions for various emerging healthcare applications; this is a critical factor adding to the development of the software segment. The growing acceptance of AI-driven healthcare informatics solutions and healthcare operational support by hospitals and other healthcare service providers is projected to grow the demand for AI diagnostics in the latter part of the projection period.

"Medical Imaging & Diagnostics Section dominates AI Healthcare Market."

Medical imaging & diagnostics section dominates the AI healthcare market and is anticipated to grow at the highest CAGR during the forecast period. The substantial development of the medical imaging and diagnostics segment is attributed to the factors such as the existence of a large volume of imaging data, high ROI offered by AI systems to radiologists in analysis and cure management, and the influx of a large number of startups in this section.

"The key drivers of AI Diagnostic Market are alliances between AI solutions providers & health facilities, and the growth of advanced AI technologies."

Growing strategic partnerships and collaborations between numerous AI solution providers and healthcare facilities help in taking forward leaps and in progressing exponentially. The alliances improve operational and diagnostic efficiencies, benefitting patients. For example, Boston based Partners HealthCare collaborated with FUJIFILM SonoSite, Inc. in August 2019 for deploying AI in transferrable ultrasound technology, valuable for point-of-care testing. Under this partnership, FUJIFILM uses the clinical expertise, datasets, and IT setup of Partners HealthCare with its portable ultrasound technology for developing AI-powered ultrasound devices. Such devices are extensively and aptly used in emergency medical procedures, reducing the time-delay between trauma and diagnosis, making fast interferences and improved patient recovery.

The major factors accelerating the development of the Global Artificial Intelligence (AI) market include the rise in the acceptance of cloud-based applications and services and the growth of big data applications across the globe. The elaborated integration of image acknowledgement technology with optical character recognition, pattern matching, and face recognition in various end-use applications such as drones, self-driving cars, and robotics will push the development of the artificial intelligence market during the forthcoming period. Such developments increase the potential of AI applications in healthcare.

"The Asia Pacific is anticipated to register vital growth in the market during the projection period."

The Asia Pacific is expected to be the most profitable market growing at an unprecedented rate during the forecast period. Governments in this region, have allocated substantial outlay for the healthcare sector and have taken initiatives for the adoption of AI-based diagnostic technologies by healthcare practitioners and other healthcare organizations. AI applications lead to increased savings to healthcare entities, better information exchange and improved clinical outcomes.

China allocates massive outlay for the healthcare sector of the country with special plans for AI adoption, among APAC countries and has delineated official layouts to digitize medical records. Japan is likely to emerge as the second-largest market share during the prediction period. These factors, combined with cost-efficiencies, are anticipated to drive the development of the market for AI in diagnostics in the Asia Pacific during the upcoming period.

The leading companies in this market are IBM Corporation, Google, Inc., NVIDIA Corporation, Microsoft Corporation, iCarbonX, Next IT Corp., CloudMex Inc., Carescore, Atomwise Inc., Zephyr Health Inc., Deep Genomics Inc., Medtronic Plc., Koninkiljke Philips N.V., and Oncora Medical, Inc. and others.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Market Breakdown & Data Triangulation
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Regional Classification of Primary Research Respondents
  • 2.5. Assumptions & Limitations

3. Executive Summary

4. Global Artificial Intelligence Diagnostics Market Insights

  • 4.1. Industry Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Growth Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. Technological Landscape
  • 4.4. Regulatory Framework
  • 4.5. Company Market Share Analysis,2019
  • 4.6. Porter's Five forces analysis
    • 4.6.1. Bargaining Power of Suppliers
    • 4.6.2. Bargaining Power of Buyers
    • 4.6.3. Threat of New Entrants
    • 4.6.4. Threat of Substitutes
    • 4.6.5. Intensity of Rivalry
  • 4.7. Strategic Outlook

5. Global Artificial Intelligence Diagnostics Market Overview

  • 5.1. Market Estimates & Forecast By Value, 2016-2026
    • 5.1.1. By Value (USD)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Solution
      • 5.2.1.1. Hardware
      • 5.2.1.2. Software
      • 5.2.1.3. Others
    • 5.2.2. By Technology
      • 5.2.2.1. Speech Recognition
      • 5.2.2.2. Querying Method
      • 5.2.2.3. Natural Language Processing
      • 5.2.2.4. Machine Learning
      • 5.2.2.5. Context Aware Processing
    • 5.2.3. By Application
      • 5.2.3.1. Imaging & Diagnostics
      • 5.2.3.2. Drug Discovery
      • 5.2.3.3. Lifestyle Management & Monitoring
      • 5.2.3.4. Emergency Room & Hospital Management
      • 5.2.3.5. Insights & Risk Analytics
      • 5.2.3.6. Wearables
      • 5.2.3.7. Virtual Assistants
      • 5.2.3.8. Others
    • 5.2.4. By End User
      • 5.2.4.1. Hospitals
      • 5.2.4.2. Pharmaceutical Organizations
      • 5.2.4.3. Diagnostics centers
      • 5.2.4.4. Clinics
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia Pacific
      • 5.2.5.4. South America
      • 5.2.5.5. Middle East & Africa

6. North America Artificial Intelligence Diagnostics Market

  • 6.1. Market Estimates & Forecast By Value, 2016-2026
    • 6.1.1. By Value (USD)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Solution
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
      • 6.2.5.1. U.S
      • 6.2.5.2. Canada

7. Europe Artificial Intelligence Diagnostics Market

  • 7.1. Market Estimates & Forecast By Value, 2016-2026
    • 7.1.1. By Value (USD)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Solution
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
      • 7.2.5.1. Germany
      • 7.2.5.2. U.K
      • 7.2.5.3. France
      • 7.2.5.4. Italy
      • 7.2.5.5. Rest of Europe

8. Asia Pacific Artificial Intelligence Diagnostics Market

  • 8.1. Market Estimates & Forecast By Value, 2016-2026
    • 8.1.1. By Value (USD)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Solution
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
      • 8.2.5.1. China
      • 8.2.5.2. India
      • 8.2.5.3. Japan
      • 8.2.5.4. South Korea
      • 8.2.5.5. Rest of APAC

9. South America Artificial Intelligence Diagnostics Market

  • 9.1. Market Estimates & Forecast By Value, 2016-2026
    • 9.1.1. By Value (USD)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Solution
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
      • 9.2.5.1. Brazil
      • 9.2.5.2. Mexico
      • 9.2.5.3. Argentina
      • 9.2.5.4. Rest of Latin America

10. Middle East & Africa Artificial Intelligence Diagnostics Market

  • 10.1. Market Estimates & Forecast By Value, 2016-2026
    • 10.1.1. By Value (USD)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Solution
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
      • 10.2.5.1. Saudi Arabia
      • 10.2.5.2. UAE
      • 10.2.5.3. South Africa
      • 10.2.5.4. Rest of MEA

11. Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)*

  • *IBM Corporation
  • *Google, Inc.
  • *NVIDIA Corporation
  • *Microsoft Corporation
  • *ICarbonX
  • *Next IT Corp.
  • *CloudMex Inc.
  • *Carescore
  • *Atomwise Inc.
  • *Zephyr Health Inc.
  • *Deep Genomics Inc.
  • *Medtronic Plc.
  • *Koninkiljke Philips N.V.
  • *Oncora Medical, Inc.

12. Strategic Recommendation